Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BEAM, BOL, KERA, LASE, LCAV, LVCI, LZRC, VISX, SNRS, STAA -- Ignore unavailable to you. Want to Upgrade?

To: neelu who wrote (56)	4/16/1999 11:02:00 PM
From: Larry Williams	Read Replies (1) \| Respond to of 253

LCAV,,,Commenting on the recent announcement by KeraVision, Stephen Joffe, M.D., chairman and chief executive officer of LCA-Vision stated, ''This approval holds continued opportunity for expanding LCAV sales of vision correction products by significantly strengthening our product offerings and providing patients with the most advanced visioncare options. LCA-Vision will continue to provide our consumers with advanced, state-of-the-art visioncare treatment and offer other alternatives to meet our patients needs and preferences.''